Anderson L B da Silveira, Fernando A C Seara, Danilo Lustrino, André S Mecawi, José Antunes-Rodrigues, Ísis C Kettelhut, Patrícia Chakur-Brum, Luis C Reis, Emerson L Olivares
{"title":"甲状腺激素诱导β1-肾上腺素受体敲除小鼠的限制性心肌病。","authors":"Anderson L B da Silveira, Fernando A C Seara, Danilo Lustrino, André S Mecawi, José Antunes-Rodrigues, Ísis C Kettelhut, Patrícia Chakur-Brum, Luis C Reis, Emerson L Olivares","doi":"10.1139/cjpp-2023-0153","DOIUrl":null,"url":null,"abstract":"<p><p>The purpose of this study was to characterize the role of β<sub>1</sub>-AR signaling and its cross-talk between cardiac renin-angiotensin system and thyroid-hormone-induced cardiac hypertrophy. T<sub>3</sub> was administered at 0.5 mg·kg<sup>-1</sup>·day<sup>-1</sup> for 10 days in β1-KO<sub>T3</sub> and WT<sub>T3</sub> groups, while control groups received vehicle alone. Echocardiography and myocardial histology was performed; cardiac and serum ANGI/ANGII and ANP and cardiac levels of p-PKA, p-ERK1/2, p-p38-MAPK, p-AKT, p-4EBP1, and ACE were measured. WT<sub>T3</sub> showed decreased IVST<sub>d</sub> and increased LVEDD versus WT<sub>sal</sub> (<i>p</i> < 0.05). β1-KO<sub>T3</sub> exhibited lower LVEDD and higher relative IVST<sub>d</sub> versus β1-KO<sub>sal</sub>, the lowest levels of ejection fraction, and the highest levels of cardiomyocyte diameter (<i>p</i> < 0.05). Cardiac ANP levels decreased in WT<sub>T3</sub> versus β1-KO<sub>T3</sub> (<i>p</i> < 0.05). Cardiac ACE expression was increased in T<sub>3</sub>-treated groups (<i>p</i> < 0.05). Phosphorylated-p38 MAPK levels were higher in WT<sub>T3</sub> versus WT<sub>sal</sub> or β1-KO<sub>T3,</sub> p-4EBP1 was elevated in β1-KO animals, and p-ERK1/2 was up-regulated in β1-KO<sub>T3</sub>. These findings suggest that β<sub>1</sub>-AR signaling is crucial for TiCH.</p>","PeriodicalId":9520,"journal":{"name":"Canadian journal of physiology and pharmacology","volume":" ","pages":"620-629"},"PeriodicalIF":1.7000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Thyroid hormone induces restrictive cardiomyopathy in β1-adrenoceptor knockout mice.\",\"authors\":\"Anderson L B da Silveira, Fernando A C Seara, Danilo Lustrino, André S Mecawi, José Antunes-Rodrigues, Ísis C Kettelhut, Patrícia Chakur-Brum, Luis C Reis, Emerson L Olivares\",\"doi\":\"10.1139/cjpp-2023-0153\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The purpose of this study was to characterize the role of β<sub>1</sub>-AR signaling and its cross-talk between cardiac renin-angiotensin system and thyroid-hormone-induced cardiac hypertrophy. T<sub>3</sub> was administered at 0.5 mg·kg<sup>-1</sup>·day<sup>-1</sup> for 10 days in β1-KO<sub>T3</sub> and WT<sub>T3</sub> groups, while control groups received vehicle alone. Echocardiography and myocardial histology was performed; cardiac and serum ANGI/ANGII and ANP and cardiac levels of p-PKA, p-ERK1/2, p-p38-MAPK, p-AKT, p-4EBP1, and ACE were measured. WT<sub>T3</sub> showed decreased IVST<sub>d</sub> and increased LVEDD versus WT<sub>sal</sub> (<i>p</i> < 0.05). β1-KO<sub>T3</sub> exhibited lower LVEDD and higher relative IVST<sub>d</sub> versus β1-KO<sub>sal</sub>, the lowest levels of ejection fraction, and the highest levels of cardiomyocyte diameter (<i>p</i> < 0.05). Cardiac ANP levels decreased in WT<sub>T3</sub> versus β1-KO<sub>T3</sub> (<i>p</i> < 0.05). Cardiac ACE expression was increased in T<sub>3</sub>-treated groups (<i>p</i> < 0.05). Phosphorylated-p38 MAPK levels were higher in WT<sub>T3</sub> versus WT<sub>sal</sub> or β1-KO<sub>T3,</sub> p-4EBP1 was elevated in β1-KO animals, and p-ERK1/2 was up-regulated in β1-KO<sub>T3</sub>. These findings suggest that β<sub>1</sub>-AR signaling is crucial for TiCH.</p>\",\"PeriodicalId\":9520,\"journal\":{\"name\":\"Canadian journal of physiology and pharmacology\",\"volume\":\" \",\"pages\":\"620-629\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian journal of physiology and pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1139/cjpp-2023-0153\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/9/25 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian journal of physiology and pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1139/cjpp-2023-0153","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/25 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Thyroid hormone induces restrictive cardiomyopathy in β1-adrenoceptor knockout mice.
The purpose of this study was to characterize the role of β1-AR signaling and its cross-talk between cardiac renin-angiotensin system and thyroid-hormone-induced cardiac hypertrophy. T3 was administered at 0.5 mg·kg-1·day-1 for 10 days in β1-KOT3 and WTT3 groups, while control groups received vehicle alone. Echocardiography and myocardial histology was performed; cardiac and serum ANGI/ANGII and ANP and cardiac levels of p-PKA, p-ERK1/2, p-p38-MAPK, p-AKT, p-4EBP1, and ACE were measured. WTT3 showed decreased IVSTd and increased LVEDD versus WTsal (p < 0.05). β1-KOT3 exhibited lower LVEDD and higher relative IVSTd versus β1-KOsal, the lowest levels of ejection fraction, and the highest levels of cardiomyocyte diameter (p < 0.05). Cardiac ANP levels decreased in WTT3 versus β1-KOT3 (p < 0.05). Cardiac ACE expression was increased in T3-treated groups (p < 0.05). Phosphorylated-p38 MAPK levels were higher in WTT3 versus WTsal or β1-KOT3, p-4EBP1 was elevated in β1-KO animals, and p-ERK1/2 was up-regulated in β1-KOT3. These findings suggest that β1-AR signaling is crucial for TiCH.
期刊介绍：
Published since 1929, the Canadian Journal of Physiology and Pharmacology is a monthly journal that reports current research in all aspects of physiology, nutrition, pharmacology, and toxicology, contributed by recognized experts and scientists. It publishes symposium reviews and award lectures and occasionally dedicates entire issues or portions of issues to subjects of special interest to its international readership. The journal periodically publishes a “Made In Canada” special section that features invited review articles from internationally recognized scientists who have received some of their training in Canada.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
